All
Azelaic acid gel is well-tolerated
March 1st 2004Washington - Sensitive skin is much more common among persons with rosacea compared to the general population, but even those rosacea patients with confirmed heightened skin sensitivity are likely to tolerate application of azelaic acid 15 percent gel (Finacea), according to the results of a prospective study undertaken by Zoe D. Draelos, M.D.
Computer Monitor: Technology for trekkers
March 1st 2004I spend about two months a year away from my office attending meetings and vacationing. Often I am many time zones away, where I want to avoid the cost and inconvenience of phoning home to the office every day. Some of my staff are not regular users of e-mail, and it is not practical to train them for occasional use of my office email system.
Azelaic acid gel is well-tolerated
March 1st 2004Washington - Sensitive skin is much more common among persons with rosacea compared to the general population, but even those rosacea patients with confirmed heightened skin sensitivity are likely to tolerate application of azelaic acid 15 percent gel (Finacea), according to the results of a prospective study undertaken by Zoe D. Draelos, M.D.
Maggot debridement therapy promising
March 1st 2004Akron, Ohio - Maggot debridement therapy (MDT), a controversial, but reportedly effective wound-healing technique, has attracted a following abroad in recent years, and is now gaining interest in the United States, as well. MDT is the medical use of live maggots or fly larvae for cleaning non-healing wounds. "MDT has been around for centuries -- so it's certainly not new, but there has been a resurgence of interest," said dermatologist and wound-care specialist Elliot N. Mostow, M.D., of Wound Care Associates of Akron (Ohio).
New topicals attack AK from myriad angles
March 1st 2004Waikoloa, Hawaii - Topical treatments for actinic keratosis can attack the problem internally and externally because of varying mechanisms of action, said James Del Rosso, D.O., as he reviewed advances in AK therapies Hawaii Dermatology Seminar.
Clinical variants dictate KS treatment
March 1st 2004Washington, D.C. - There are several clinical variants of Kaposi's sarcoma (KS), and appropriate treatment and response to treatment differ according to the clinical variant, according to Katie Pang, M.D., a clinical research fellow working with Dr. Stephen Tyring at the Center for Clinical Studies in Houston, Texas. The four major clinical variants are classic KS, KS in iatrogenically immunosuppressed patients, AIDS-related epidemic KS, and African endemic KS. HHV-8 is the etiological agent of all of the clinical types of KS.
New anti-dandruff foam looks promising
March 1st 2004Washington - A novel thermophobic foam containing three active ingredients to fight dandruff is at least as effective as standard anti-dandruff treatment, and offers the advantages of a non-greasy formulation that is fast-acting and not irritating to the hair or scalp, according to Massimo Milani, M.D., the medical director and head of technology and development at Mipharm SpA in Milan, Italy.
Less is more in rosacea patients' routine
March 1st 2004Waikoloa, Hawaii- When counseling rosacea patients on routine skincare products, the dermatologist's main mission is to keep the skincare simple and thus avoid the irritation that triggers an exacerbation of rosacea, according to Zoe D. Draelos, M.D.
To boutique, or not to boutique: that is the question
March 1st 2004Boutique. Concierge. Express service. There are a variety of names but the end result is the same: patients pay an annual retainer, and for that money - usually between $1000 to $2000 - patients receive a variety of special services: a smaller patient base which allows for no-wait appointments, longer appointments, and quicker return phone calls. It probably can not be called a trend yet, but a number of physicians around the country have dropped Medicare and others have stopped accepting managed care. Now, this new twist is being added - personalized medical care - for a fee.
Langerhans sarcoma: rare neoplasm
March 1st 2004Washington - Langerhans cell sarcoma is a rare neoplasm that can involve multiple organs, including lymph nodes, bone, lung, bone marrow, skin, and brain. A single, cutaneous tumor is an unusual primary presentation, said Tammie Ferringer, M.D., dermatopathology fellow at the Medical University of South Carolina.
Cryosurgery: cost-effective cancer cure
March 1st 2004Washington - Cryosurgery should be offered as a treatment option for a variety of skin cancers because it is an effective modality with numerous advantages, said Gloria F. Graham, M.D., at the annual meeting of the American Academy of Dermatology.